Cargando…

Harnessing the Immune System to Fight Multiple Myeloma

SIMPLE SUMMARY: Multiple myeloma treatment has developed enormously within the last two decades. Most recently immunotherapies have been introduced. Monoclonal antibodies targeting the plasma cell surface marker CD38, daratumumab and isatuximab, have revolutionized the standard of care treatment, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Krejcik, Jakub, Barnkob, Mike Bogetofte, Nyvold, Charlotte Guldborg, Larsen, Thomas Stauffer, Barington, Torben, Abildgaard, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467095/
https://www.ncbi.nlm.nih.gov/pubmed/34572773
http://dx.doi.org/10.3390/cancers13184546